Covered recipient · General Payments record
SUSAN CASH
Allopathic & Osteopathic Physicians Surgery
General Payments · PY2023–2024
$834.54
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $619.95 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ORGANOGENESIS INC. | $191.77 | 6 |
| Reapplix Inc. | $148.40 | 3 |
| Kerecis Limited | $113.98 | 1 |
| Smith & Nephew, Inc. | $60.59 | 3 |
| Solventum Corporation | $47.33 | 3 |
| TACTILE SYSTEMS TECHNOLOGY INC | $30.91 | 1 |
| AngioDynamics, Inc. | $26.97 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AngioDynamics, Inc. | $26.97 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1095070038 | CMS |
| Kerecis Limited | $113.98 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120119788 | CMS |
| Organogenesis Inc. | $15.61 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145422328 | CMS |
| Organogenesis Inc. | $10.21 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145422330 | CMS |
| Organogenesis Inc. | $74.80 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145422332 | CMS |
| Organogenesis Inc. | $32.81 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145422334 | CMS |
| Organogenesis Inc. | $29.50 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145422336 | CMS |
| Organogenesis Inc. | $28.84 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145422338 | CMS |
| Reapplix Inc. | $114.22 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144459908 | CMS |
| Reapplix Inc. | $22.23 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144460194 | CMS |
| Reapplix Inc. | $11.95 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144460290 | CMS |
| Smith+Nephew, Inc. | $21.84 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149584163 | CMS |
| Smith+Nephew, Inc. | $15.90 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149584161 | CMS |
| Smith+Nephew, Inc. | $22.85 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149584165 | CMS |
| Solventum Corporation | $13.72 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144065425 | CMS |
| Solventum Corporation | $16.53 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144065427 | CMS |
| Solventum Corporation | $17.08 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144065423 | CMS |
| Tactile Systems Technology Inc | $30.91 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082374687 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.